Development, Evaluation and Stability Studies of Zidovudine and Lamivudine (ZILA) Tablet Dosage Form
暂无分享,去创建一个
[1] J. Varshosaz,et al. Development and evaluation of a monolithic floating drug delivery system for acyclovir. , 2012, Chemical & pharmaceutical bulletin.
[2] Mike Youle,et al. Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection , 1997, PharmacoEconomics.
[3] Rakesh Patel,et al. FORMULATION DEVELOPMENT AND PROCESS OPTIMIZATION OF THEOPHYLLINE SUSTAINED RELEASE MATRIX TABLET. , 2009 .
[4] O. Ramilo,et al. Zidovudine, Lamivudine, and Abacavir Have Different Effects on Resting Cells Infected with Human Immunodeficiency Virus In Vitro , 2004, Antimicrobial Agents and Chemotherapy.
[5] Michael Levin,et al. Supac-Mr: Modified Release Solid Oral Dosage Forms—Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation , 2001 .
[6] E. De Clercq. New developments in anti-HIV chemotherapy , 2001, Current medicinal chemistry.
[7] J. Beach. Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions. , 1998, Clinical therapeutics.
[8] D. Kuritzkes,et al. Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter , 1995 .
[9] Arthur I. Vogel,et al. Vogel's Textbook of Quantitative Chemical Analysis , 1989 .
[10] Joseph L. Kanig,et al. The theory and practice of industrial pharmacy , 1970 .
[11] S. H. Fox. The Theory and Practice of Industrial Pharmacy , 1970 .
[12] R L Carr,et al. EVALUATING FLOW PROPERTIES OF SOLIDS , 1965 .
[13] David Train,et al. SOME ASPECTS OF THE PROPERTY OF ANGLE OF REPOSE OF POWDERS , 1958, The Journal of pharmacy and pharmacology.